The Joint Statement on Strengthening the Antibiotic R&D Pipeline by Rewarding Innovation emphasises the escalating global threat of antimicrobial resistance (AMR) and underscores the necessity for collaborative efforts between the public and private sectors. Highlighting the unmet need for innovative antibiotics, especially for vulnerable populations like children, the statement stresses the importance of antibiotic stewardship. The statement applauds current initiatives like the G7 health ministers’ actions against AMR but calls for intensified and continuous efforts in the face of the mounting AMR crisis. The urgency of the statement’s recommendations is underscored as essential for addressing the multifaceted challenges posed by AMR.
Specific actions for global leaders articulated include:
- Urging the reinforcement of the antibiotic research and development pipeline;
- Ensuring swift access to antibiotics;
- Capitalising on vaccine opportunities;
- Immediate implementation of recommendations to establish an innovative and sustainable ecosystem capable of effectively combating AMR.
